{"title_page": "Epsiprantel", "text_new": "{{Drugbox\n| drug_name =\n| IUPAC_name = 2-(Cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydropyrazino[2,1-''a''][2]benzazepin-4(1''H'')-one\n| image = Epsiprantel 200.svg\n| width = 175\n\n<!--Clinical data -->\n| tradename = Cestex\n| Drugs.com =\n| MedlinePlus =\n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B / C / D / X -->\n| pregnancy_category =\n| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->\n| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->\n| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->\n| legal_US = Rx-only\n| legal_status =\n| routes_of_administration = [[Oral administration|By mouth]] ([[Tablet (pharmacy)|tablets]])\n\n<!--Pharmacokinetic data -->\n| bioavailability = Minimal<ref name=\"PI\">{{cite web|title=Cestex (epsiprantel) Veterinary Tablets. Prescribing Information|url=https://www.zoetisus.com/_locale-assets/mcm-portal-assets/products/pdf/cestex-zoetis-pi.pdf|publisher=Zoetis Inc. Kalamazoo, MI 49007|accessdate=2 October 2016}}</ref>\n| protein_bound =\n| metabolism =\n| elimination_half-life =\n| excretion =\n\n<!--Identifiers -->\n| CAS_number = 98123-83-2\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 0C1SPQ0FSR\n| PubChem = 72026\n| ChemSpiderID = 65020\n| ChEMBL = 64979\n| ATCvet = yes\n| ATC_prefix = P52\n| ATC_suffix = AA04\n| DrugBank =\n| synonyms = BRL 38705\n\n<!--Chemical data -->\n| C=20 | H=26 | N=2 | O=2\n| molecular_weight = 326.433 g/mol\n| smiles = O=C4N2C(c1c(cccc1)CCC2)CN(C(=O)C3CCCCC3)C4\n| StdInChI = 1S/C20H26N2O2/c23-19-14-21(20(24)16-8-2-1-3-9-16)13-18-17-11-5-4-7-15(17)10-6-12-22(18)19/h4-5,7,11,16,18H,1-3,6,8-10,12-14H2\n| StdInChIKey = LGUDKOQUWIHXOV-UHFFFAOYSA-N\n}}\n\n'''Epsiprantel''' (trade name '''Cestex''') is a [[veterinary drug]] which is used as an [[anthelmintic]] against [[tapeworm]]s such as ''[[Echinococcus granulosus]]''.<ref>{{cite journal |author1=Arru, E. |author2=Garippa, G. |author3=Manger, B. R. | title = Efficacy of epsiprantel against Echinococcus granulosus infections in dogs | journal = Research in Veterinary Science | year = 1990 | volume = 49 | issue = 3 | pages = 378\u2013379 | pmid = 2267429}}</ref>\n\n==Indications==\nIt is indicated for the removal of [[Cestoda|cestodes]] (tapeworms) in cats (''[[Dipylidium caninum]]'' and ''[[Taenia taeniaeformis]]'') and dogs (''Dipylidium caninum'' and ''[[Taenia pisiformis]]'') 7 weeks of age and older.<ref name=\"PI\" />\n\n==References==\n{{reflist}}\n\n{{anthelmintics}}\n\n[[Category:Anthelmintics]]\n[[Category:Veterinary drugs]]\n\n{{antiinfective-drug-stub}}\n", "text_old": "{{Drugbox\n| drug_name =\n| IUPAC_name = 2-(Cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydropyrazino[2,1-''a''][2]benzazepin-4(1''H'')-one\n| image = Epsiprantel 200.svg\n| width = 175\n\n<!--Clinical data -->\n| tradename = Cestex\n| Drugs.com =\n| MedlinePlus =\n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B / C / D / X -->\n| pregnancy_category =\n| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->\n| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->\n| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->\n| legal_US = Rx-only\n| legal_status =\n| routes_of_administration = [[Oral administration|By mouth]] ([[Tablet (pharmacy)|tablets]])\n\n<!--Pharmacokinetic data -->\n| bioavailability = Minimal<ref name=\"PI\">{{cite web|title=Cestex (epsiprantel) Veterinary Tablets. Prescribing Information|url=https://www.zoetisus.com/_locale-assets/mcm-portal-assets/products/pdf/cestex-zoetis-pi.pdf|publisher=Zoetis Inc. Kalamazoo, MI 49007|accessdate=2 October 2016}}</ref>\n| protein_bound =\n| metabolism =\n| elimination_half-life =\n| excretion =\n\n<!--Identifiers -->\n| CAS_number = 98123-83-2\n| PubChem = 72026\n| ChemSpiderID = 65020\n| ChEMBL = 64979\n| ATCvet = yes\n| ATC_prefix = P52\n| ATC_suffix = AA04\n| DrugBank =\n| synonyms = BRL 38705\n\n<!--Chemical data -->\n| C=20 | H=26 | N=2 | O=2\n| molecular_weight = 326.433 g/mol\n| smiles = O=C4N2C(c1c(cccc1)CCC2)CN(C(=O)C3CCCCC3)C4\n| StdInChI = 1S/C20H26N2O2/c23-19-14-21(20(24)16-8-2-1-3-9-16)13-18-17-11-5-4-7-15(17)10-6-12-22(18)19/h4-5,7,11,16,18H,1-3,6,8-10,12-14H2\n| StdInChIKey = LGUDKOQUWIHXOV-UHFFFAOYSA-N\n}}\n\n'''Epsiprantel''' (trade name '''Cestex''') is a [[veterinary drug]] which is used as an [[anthelmintic]] against [[tapeworm]]s such as ''[[Echinococcus granulosus]]''.<ref>{{cite journal |author1=Arru, E. |author2=Garippa, G. |author3=Manger, B. R. | title = Efficacy of epsiprantel against Echinococcus granulosus infections in dogs | journal = Research in Veterinary Science | year = 1990 | volume = 49 | issue = 3 | pages = 378\u2013379 | pmid = 2267429}}</ref>\n\n==Indications==\nIt is indicated for the removal of [[Cestoda|cestodes]] (tapeworms) in cats (''[[Dipylidium caninum]]'' and ''[[Taenia taeniaeformis]]'') and dogs (''Dipylidium caninum'' and ''[[Taenia pisiformis]]'') 7 weeks of age and older.<ref name=\"PI\" />\n\n==References==\n{{reflist}}\n\n{{anthelmintics}}\n\n[[Category:Anthelmintics]]\n[[Category:Veterinary drugs]]\n\n{{antiinfective-drug-stub}}\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/Epsiprantel"}
